Paradoxically, chronic IL-1β exposure leads to sustained NF-κB activation, which subsequently suppresses PPARγ and C/EBPα expression, ultimately inhibiting adipogenesis and inducing insulin resistance [37, 38]. The gene discussed is CEBPA; the disease is Insulin resistance.